Sector
PharmaceuticalsOpen
₹1,822Prev. Close
₹1,820.2Turnover(Lac.)
₹8,268.36Day's High
₹1,826.5Day's Low
₹1,768.352 Week's High
₹1,868.852 Week's Low
₹750Book Value
₹170.06Face Value
₹5Mkt Cap (₹ Cr.)
28,823.31P/E
0EPS
0Divi. Yield
05 Jun 2024
12:00 AM
AGM
Announcement Date: 05 Jun, 2024
23 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 77 | 72 | 72 | 55 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,719 | 1,681 | 2,140 | 1,551 |
Net Worth | 1,796 | 1,753 | 2,212 | 1,606 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,372 | 987 | 890.06 | 2,477.29 |
yoy growth (%) | 39 | 10.89 | -64.07 | 7.82 |
Raw materials | -476 | -416 | -313.29 | -975.36 |
As % of sales | 34.69 | 42.14 | 35.19 | 39.37 |
Employee costs | -261 | -293 | -325.46 | -506.44 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -184 | -481 | -483.68 | 103.92 |
Depreciation | -171 | -184 | -173.39 | -106.24 |
Tax paid | 44 | 231 | 158 | -35.26 |
Working capital | 197 | -66.03 | -165.93 | -147.06 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 39 | 10.89 | -64.07 | 7.82 |
Op profit growth | -260.86 | 3.65 | -141.23 | 122.91 |
EBIT growth | -131.67 | 6.63 | -196.34 | -4.86 |
Net profit growth | -123.6 | -356.57 | -436.61 | -49.92 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 3,012 | 2,798 | 2,651 | 3,230 | 2,708 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,012 | 2,798 | 2,651 | 3,230 | 2,708 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 62 | 83 | 122 | 20 | 1,476 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.4 | 95.58 | 4,08,666.73 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,790.5 | 81.57 | 1,80,131.05 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,482.4 | 24.88 | 1,19,745.08 | 1,485.4 | 1.08 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,504.6 | 62.68 | 1,18,597.8 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,639.3 | 57.84 | 1,08,985.15 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
H F Khorakiwala
Managing Director
Murtaza H Khorakiwala
Executive Director
Huzaifa H Khorakiwala
Independent Director
Tasneem Mehta
Independent Director
Vinesh Kumar Jairath
Non-Executive & Non-Independent Director
Zahabiya Khorakiwala
Independent Director
Akhilesh Gupta
Independent Director
Amelia Fernandes
Company Sec. & Compli. Officer
Rashmi Mamtura
Independent Director
Ahmad Javed
D-4 MIDC,
Chikalthana,
Maharashtra - 431006
Tel: 91-240-6694444
Website: http://www.wockhardt.com
Email: investorrelations@wockhardt.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Wockhardt Limited, incorporated in July, 1999 is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. The Company is Indias leadi...
Read More
Reports by Wockhardt Ltd
What is the Wockhardt Ltd share price today?
What is the Market Cap of Wockhardt Ltd?
What is the PE and PB ratio of Wockhardt Ltd?
What is the 52 Week High and Low of Wockhardt Ltd?
What is the CAGR of Wockhardt Ltd?
What is the shareholding pattern of Wockhardt Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
